Zonisamide
Zyntex provides high-purity Zonisamide. As a unique benzisoxazole derivative, this API provides broad-spectrum anticonvulsant activity and neuroprotective benefits, making it essential for advanced epilepsy and Parkinson’s therapies.
Description
Comprehensive Product Overview
In the field of modern neurology, Zonisamide is recognized for its versatile pharmacological profile. First, it blocks voltage-sensitive sodium channels and T-type calcium channels, which effectively stabilizes neuronal membranes and suppresses hypersynchronous firing. As a result, it provides robust control over various seizure types. Zyntex provides Zonisamide with a meticulously controlled particle size to optimize the dissolution rate, which is critical for achieving steady-state plasma concentrations in patients with refractory epilepsy.
Zyntex also supplies Zonisamide for its emerging role in treating the motor symptoms of Parkinson’s disease. In addition to its ion channel modulation, it acts as a moderate carbonic anhydrase inhibitor and enhances dopaminergic and GABAergic transmission. Moreover, its potential neuroprotective properties—attributed to its ability to scavenge free radicals—make it a subject of intense clinical interest. Consequently, our product helps pharmaceutical manufacturers develop multi-functional therapies that address both seizure management and neurodegenerative progression. Finally, our rigorous batch testing ensures that every gram of Zonisamide meets the highest international safety and efficacy standards.
Key Pharmaceutical Applications
This specialized neurological API is a cornerstone in the following therapeutic areas:
🧠 Epilepsy Management
Used as adjunctive therapy in adults and pediatric patients for the treatment of partial-onset seizures and certain generalized epilepsies.
👴 Parkinson’s Disease
Applied to reduce “off” time and improve motor function in patients who do not respond adequately to levodopa monotherapy.
🧪 Migraine Prophylaxis
Utilized in clinical research and off-label applications for preventing chronic migraine headaches through neuronal stabilization.
🔬 Neuroprotection Research
Serves as a key compound for studying the prevention of oxidative stress and glutamate-induced toxicity in nerve cells.
Technical Specifications
| Parameter | Specification Standard |
|---|---|
| Product Name | Zonisamide |
| CAS Number | 68291-97-4 |
| Molecular Formula | C8H8N2O3S |
| Assay (Purity) | Min. 99.0% |
🔬 Scientific Data: For detailed pharmacological properties and safety data, consult: PubChem Entry: Zonisamide (External Link)
